FDA decree limits Genzyme drug distribution; WHO scolds EU for customs games delaying Indian drugs;

> Via consent decree, the FDA is restricting Genzyme's U.S. distribution of thyroid cancer drug Thyrogen. FDA Statement

> WHO calls EU on counterfeit/patent gamesmanship in slowing drug shipments from India. Article

> Canadian ointment and creams maker Contract Pharmaceuticals is closing its Buffalo, NY, facility by the end of 2011, eliminating 260 jobs. Article

> Inefficiency and lack of coordination between India's drug-purchasing and drug-manufacturing agencies has led to their merger by Health Minister Maithripala Sirisena. Article

> The Abbott Labs acquisition of India's Piramal Healthcare Solutions will drive more cross-border M&A activity, says ARC Advisory. Post

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.